These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 22487072)

  • 41. Outcome of transarterial chemoembolization-based multi-modal treatment in patients with unresectable hepatocellular carcinoma.
    Song DS; Nam SW; Bae SH; Kim JD; Jang JW; Song MJ; Lee SW; Kim HY; Lee YJ; Chun HJ; You YK; Choi JY; Yoon SK
    World J Gastroenterol; 2015 Feb; 21(8):2395-404. PubMed ID: 25741147
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hepatic resection after transarterial chemoembolization increases overall survival in large/multifocal hepatocellular carcinoma: a retrospective cohort study.
    Chen J; Lai L; Lin Q; Huang W; Cai M; Zhu K; Huang M
    Oncotarget; 2017 Jan; 8(1):408-417. PubMed ID: 27880724
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combination of repeated single-session percutaneous ethanol injection and transarterial chemoembolisation compared to repeated single-session percutaneous ethanol injection in patients with non-resectable hepatocellular carcinoma.
    Dettmer A; Kirchhoff TD; Gebel M; Zender L; Malek NP; Panning B; Chavan A; Rosenthal H; Kubicka S; Krusche S; Merkesdal S; Galanski M; Manns MP; Bleck JS
    World J Gastroenterol; 2006 Jun; 12(23):3707-15. PubMed ID: 16773687
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An inflammation-based prognostic index predicts survival advantage after transarterial chemoembolization in hepatocellular carcinoma.
    Pinato DJ; Sharma R
    Transl Res; 2012 Aug; 160(2):146-52. PubMed ID: 22677364
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transarterial chemoembolization versus supportive therapy in the palliative treatment of unresectable intrahepatic cholangiocarcinoma.
    Park SY; Kim JH; Yoon HJ; Lee IS; Yoon HK; Kim KP
    Clin Radiol; 2011 Apr; 66(4):322-8. PubMed ID: 21356394
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treating unresectable intrahepatic cholangiocarcinoma with transarterial chemoembolization and an unusual progression with cardiac involvement.
    Mumdzhiev N; Borisov B; Tenev R; Radicheva M
    Folia Med (Plovdiv); 2023 Apr; 65(2):326-330. PubMed ID: 37144321
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Systemic chemotherapy plus transarterial chemoembolization versus systemic chemotherapy alone for unresectable intrahepatic cholangiocarcinoma: a multicenter retrospective cohort study.
    Jiang N; Zhang Z; Yin X; Qiu H; Yan W; Hao Y; Yang W; Li H; Xu A; Mu K
    Radiol Med; 2024 Apr; 129(4):631-642. PubMed ID: 38355907
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effectiveness of transarterial chemoembolization in recurrent hepatocellular-cholangiocarcinoma after resection.
    Na SK; Choi GH; Lee HC; Shin YM; An J; Lee D; Shim JH; Kim KM; Lim YS; Chung YH; Lee YS
    PLoS One; 2018; 13(6):e0198138. PubMed ID: 29879137
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Survival analysis of high-intensity focused ultrasound therapy vs. transarterial chemoembolization for unresectable hepatocellular carcinomas.
    Cheung TT; Poon RT; Jenkins CR; Chu FS; Chok KS; Chan AC; Tsang SH; Dai WC; Yau TC; Chan SC; Fan ST; Lo CM
    Liver Int; 2014 Jul; 34(6):e136-43. PubMed ID: 24451026
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hepatic resection versus transarterial chemoembolization in infiltrative hepatocellular carcinoma: A multicenter study.
    Wang Y; Shen J; Feng S; Liang R; Lai J; Li D; Peng B; Wang Z; Huang C; Kuang M
    J Gastroenterol Hepatol; 2020 Dec; 35(12):2220-2228. PubMed ID: 32246889
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of unresectable cholangiocarcinoma with gemcitabine-based transcatheter arterial chemoembolization (TACE): a single-institution experience.
    Gusani NJ; Balaa FK; Steel JL; Geller DA; Marsh JW; Zajko AB; Carr BI; Gamblin TC
    J Gastrointest Surg; 2008 Jan; 12(1):129-37. PubMed ID: 17851723
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Preoperative chemoembolization in patients with hepatocellular carcinoma undergoing liver transplantation: influence of emergent versus elective procedures on patient survival and tumor recurrence rate.
    Stockland AH; Walser EM; Paz-Fumagalli R; McKinney JM; May GR
    Cardiovasc Intervent Radiol; 2007; 30(5):888-93. PubMed ID: 17619218
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Influence of postoperative adjuvant transarterial chemoembolization on the prognosis of early-stage intrahepatic cholangiocarcinoma: a single center study.
    Liu G; Guo W; Wang H; Liu W; Lei L; Xie Q; Li X; Zou S; Wang P; Zhou H; Hu H
    Ann Palliat Med; 2021 Apr; 10(4):3673-3683. PubMed ID: 33691434
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hepatic resection versus transarterial lipiodol chemoembolization as the initial treatment for large, multiple, and resectable hepatocellular carcinomas: a prospective nonrandomized analysis.
    Luo J; Peng ZW; Guo RP; Zhang YQ; Li JQ; Chen MS; Shi M
    Radiology; 2011 Apr; 259(1):286-95. PubMed ID: 21330557
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Downstaging disease in patients with hepatocellular carcinoma outside of Milan criteria: strategies using drug-eluting bead chemoembolization.
    Green TJ; Rochon PJ; Chang S; Ray CE; Winston H; Ruef R; Kreidler SM; Glueck DH; Shulman BC; Brown AC; Durham J
    J Vasc Interv Radiol; 2013 Nov; 24(11):1613-22. PubMed ID: 24060436
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A new ALBI-based model to predict survival after transarterial chemoembolization for BCLC stage B hepatocellular carcinoma.
    Lee IC; Hung YW; Liu CA; Lee RC; Su CW; Huo TI; Li CP; Chao Y; Lin HC; Hou MC; Huang YH
    Liver Int; 2019 Sep; 39(9):1704-1712. PubMed ID: 31319016
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Post-embolization syndrome as an early predictor of overall survival after transarterial chemoembolization for hepatocellular carcinoma.
    Mason MC; Massarweh NN; Salami A; Sultenfuss MA; Anaya DA
    HPB (Oxford); 2015 Dec; 17(12):1137-44. PubMed ID: 26374137
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Trans-arterial chemo-embolization is safe and effective for very elderly patients with hepatocellular carcinoma.
    Cohen MJ; Bloom AI; Barak O; Klimov A; Nesher T; Shouval D; Levi I; Shibolet O
    World J Gastroenterol; 2013 Apr; 19(16):2521-8. PubMed ID: 23674854
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Predictive Factors of Tumor Recurrence and Survival in Patients with Hepatocellular Carcinoma treated with Transarterial Chemoembolization.
    Cerban R; Ester C; Iacob S; Grasu M; Pâslaru L; Dumitru R; Lupescu I; Constantin G; Croitoru A; Gheorghe L
    J Gastrointestin Liver Dis; 2018 Dec; 27(4):409-417. PubMed ID: 30574623
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Combined hepatectomy and radiofrequency ablation versus TACE in improving survival of patients with unresectable BCLC stage B HCC.
    Hou YF; Wei YG; Yang JY; Wen TF; Xu MQ; Yan LN; Li B
    Hepatobiliary Pancreat Dis Int; 2016 Aug; 15(4):378-85. PubMed ID: 27498577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.